by Pete Gagnon
Volume 5, Issue 1 (Spring 2006)
The outstanding success and safety record of first generation monoclonal products has created an immense increase in the number of product candidates that need to be evaluated clinically. The concept of platform purification has emerged in response to this need. A platform is a semigeneric, multistep purification procedure that can be applied to a wide range of monoclonal antibodies without extensive method-scouting and optimization. This approach can substantially accelerate process development and hasten inception of clinical trials…
Citation:
Gagnon P. The Quest for a Generic IgG Purification Process. BioProcess J, 2006; 5(1): 31-36. https://doi.org/10.12665/J51.Gagnon